US 10280423
Compositions and methods for modulating complement factor B expression
granted A61PA61P13/12A61P27/02
Quick answer
US patent 10280423 (Compositions and methods for modulating complement factor B expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61P, A61P13/12, A61P27/02, A61P37/02, A61P43/00